Concepedia

Tomislav Dragovich

TD

40

Publications

3.6K

Citations

26

H-Index

2004

Active since

Affiliations

University of Arizona(Current)

The University of Texas MD Anderson Cancer Center

Banner MD Anderson Cancer Center

Arizona Oncology

Vanderbilt University

Tomislav Dragovich is an author at University of Arizona specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2004–2023

40

Publications

40

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

, , +8

Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser et al. · Journal of Clinical Oncology · 2006 · 313 citations · Full text

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Mitesh J. Borad, Shantan Reddy, Nathan Bahary et al. · Journal of Clinical Oncology · 2014 · 186 citations · Full text

Stability of Phosphoprotein as a Biological Marker of Tumor Signaling

Amanda F. Baker, Tomislav Dragovich, Nathan T. Ihle et al. · Clinical Cancer Research · 2005 · 168 citations

A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer

Tomislav Dragovich, David S. Mendelson, Sandra Kurtin et al. · Cancer Chemotherapy and Pharmacology · 2006 · 137 citations

, , +4

Rows per page

1–5 of 40